INmune Bio Inc.

7.90
-0.01 (-0.13%)
At close: Jan 28, 2025, 1:59 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 155.00K 374.00K 181.00K 10.92K 77.69M n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 155.00K 374.00K 181.00K 10.92K 77.69M n/a n/a n/a n/a
Operating Income -29.74M -25.95M -29.15M -12.23M -7.76M -12.44M -981.48K -227.49K -48.87K
Interest Income n/a n/a n/a n/a 77.69K n/a n/a n/a n/a
Pretax Income -30.01M -27.30M -30.34M -12.10M -7.68M -12.44M -831.49K -277.49K -48.87K
Net Income -30.01M -28.65M -30.34M -12.10M -9.14M -12.44M -831.49K -277.49K -48.87K
Selling & General & Admin 9.62M 9.26M 8.79M 6.32M 6.02M 11.33M 546.12K 126.00K 48.87K
Research & Development 20.27M 17.07M 20.54M 5.92M 3.28M 1.11M 435.36K 101.50K n/a
Other Expenses n/a -1.35M -1.19M 128.52K n/a n/a -6 n/a n/a
Operating Expenses 29.90M 26.32M 29.33M 12.24M 9.30M 12.44M 981.48K 227.49K 48.87K
Interest Expense n/a 1.35M n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a -146.60K
Cost & Expenses 29.90M 26.32M 29.33M 12.24M 9.30M 12.44M 981.48K 227.49K 48.87K
Income Tax n/a 1.35M -29.15M -12.23M 1.46M -161.14K -1.13M -177.49K n/a
Shares Outstanding (Basic) 17.98M 17.93M 16.13M 11.99M 10.27M 11.22M 11.22M 11.22M 11.22M
Shares Outstanding (Diluted) 17.98M 17.93M 16.13M 11.99M 10.27M 11.22M 11.22M 11.22M 11.22M
EPS (Basic) -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.07 -0.02 -0.00
EPS (Diluted) -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.07 -0.02 -0.00
EBITDA -29.74M n/a n/a n/a n/a n/a 149.99K -50.00K 146.60K
Depreciation & Amortization n/a 25.95M 29.15M 12.23M 9.30M 12.44M 981.48K 227.49K 195.47K

Create Price Alert on INMB

Your price alert will notify you when the stock price is above 7.90.

Add to Watchlist